Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)

China flag China · Delayed Price · Currency is CNY
3.220
+0.080 (2.55%)
At close: Mar 6, 2026
9.15%
Market Cap 4.78B
Revenue (ttm) 7.32B
Net Income (ttm) -85.17K
Shares Out 1.48B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend 0.01 (0.25%)
Ex-Dividend Date n/a
Volume 29,295,150
Average Volume 37,574,337
Open 3.120
Previous Close 3.140
Day's Range 3.110 - 3.220
52-Week Range 2.510 - 4.690
Beta 0.36
RSI 44.44
Earnings Date Apr 23, 2026

About SHE:002589

Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institutions in China. It operates through the Drug and Equipment Distribution, In Vitro Diagnostics, Pharmaceutical Logistics, Traditional Chinese Medicine, and Microbiome Medicine segments. The company engages in the processing, manufacture, sale, and wholesale of Chinese medicinal materials, herbal medicine, and patent medicine. It is also involved in the wholesale of biochemical, psychotropic, narcotic, and toxic drugs for medical use... [Read more]

Sector Healthcare
Founded 2004
Employees 2,897
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002589
Full Company Profile

Financial Performance

In 2024, SHE:002589's revenue was 7.97 billion, a decrease of -0.85% compared to the previous year's 8.03 billion. Earnings were 20.62 million, an increase of 1.50%.

Financial Statements

News

There is no news available yet.